Synapse

← Translational and Clinical Pharmacology

Papers in Translational and Clinical Pharmacology

Page 2 · newest first

  1. Quantification of OATP1B1 endogenous metabolites coproporphyrin I and III in human urineTranslational and Clinical Pharmacology · 2023
  2. Phage-host-immune system dynamics in bacteriophage therapy: basic principles and mathematical modelsTranslational and Clinical Pharmacology · 2023
  3. Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulationTranslational and Clinical Pharmacology · 2023
  4. Analysis of the distribution of trial sites in South Korea using social network analysisTranslational and Clinical Pharmacology · 2023
  5. Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjectsTranslational and Clinical Pharmacology · 2023
  6. Effects of rifampin coadministration on the pharmacokinetics of digoxin: a real-world data approachTranslational and Clinical Pharmacology · 2023
  7. Building and analyzing machine learning-based warfarin dose prediction models using scikit-learnTranslational and Clinical Pharmacology · 2022
  8. Comparison of international guidelines for early-phase clinical trials of cellular and gene therapy productsTranslational and Clinical Pharmacology · 2022
  9. Lessons from a multicenter clinical trial with an approved wearable electrocardiogram: issues and practical considerationsTranslational and Clinical Pharmacology · 2022
  10. A case of sinus arrest in atrial fibrillation with pulmonary embolism after flecainide ingestionTranslational and Clinical Pharmacology · 2022
  11. Melatonin and melatonergic drugs in sleep disordersTranslational and Clinical Pharmacology · 2022
  12. Factors influencing decision making and antibiotic prescribing patterns for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) among non-infectious physicians in Thailand: a qualitative studyTranslational and Clinical Pharmacology · 2022
  13. Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case reportTranslational and Clinical Pharmacology · 2022
  14. Predicting the systemic exposure and lung concentration of nafamostat using physiologically-based pharmacokinetic modelingTranslational and Clinical Pharmacology · 2022
  15. Evaluation of food effects on the pharmacokinetics of Pelargonium sidoides and Coptis with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjectsTranslational and Clinical Pharmacology · 2022
  16. Prediction of metabolizing enzyme-mediated clinical drug interactions using in vitro informationTranslational and Clinical Pharmacology · 2022
  17. Ultrafast liquid chromatography-tandem mass spectrometry determination of donepezil in human plasma: application to a bioequivalence studyTranslational and Clinical Pharmacology · 2022
  18. Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugsTranslational and Clinical Pharmacology · 2022
  19. Stability of acetylsalicylic acid in human blood collected using volumetric absorptive microsampling (VAMS) under various drying conditionsTranslational and Clinical Pharmacology · 2022
  20. Physiologically-based pharmacokinetic modeling of nafamostat to support dose selection for treatment of pediatric patients with COVID-19Translational and Clinical Pharmacology · 2022
  21. A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsyTranslational and Clinical Pharmacology · 2021
  22. Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophreniaTranslational and Clinical Pharmacology · 2021
  23. Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjectsTranslational and Clinical Pharmacology · 2021
  24. Brief introduction to parametric time to event modelTranslational and Clinical Pharmacology · 2021
  25. Predicting human pharmacokinetics from preclinical data: clearanceTranslational and Clinical Pharmacology · 2021
  26. The use of real-world data in drug repurposingTranslational and Clinical Pharmacology · 2021
  27. Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimenTranslational and Clinical Pharmacology · 2021
  28. Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platformTranslational and Clinical Pharmacology · 2021
  29. A validated simple LC-MS/MS method for quantifying trimethylamineN-oxide (TMAO) using a surrogate matrix and its clinical applicationTranslational and Clinical Pharmacology · 2021
  30. Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MSTranslational and Clinical Pharmacology · 2021
  31. Insulin sensitization causes accelerated sinus nodal dysfunction through autophagic dysregulation in hypertensive miceTranslational and Clinical Pharmacology · 2021
  32. Trends of clinical trials from 2017 to 2019 in Korea: an integrated analysis based on the Ministry of Food and Drug Safety (MFDS) and the Clinical Research Information Service (CRIS) registriesTranslational and Clinical Pharmacology · 2021
  33. Comparison of pharmacokinetics and safety characteristics between two olopatadine hydrochloride 5 mg tablet formulations in healthy Korean subjectsTranslational and Clinical Pharmacology · 2021
  34. QTc prolongation in patients with COVID-19: a retrospective chart reviewTranslational and Clinical Pharmacology · 2021
  35. Medication selection for the treatment of acute infective diarrhea in Thai pharmacies: a qualitative studyTranslational and Clinical Pharmacology · 2021
  36. The possibility of low isomerization of β-lapachone in the human bodyTranslational and Clinical Pharmacology · 2021
  37. Cognitive improvement effect of gintonin might be associated with blood-brain barrier permeability enhancement: dynamic contrast-enhanced MRI pilot studyTranslational and Clinical Pharmacology · 2021
  38. Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjectsTranslational and Clinical Pharmacology · 2021
  39. Introduction to dynamical systems analysis in quantitative systems pharmacology: basic concepts and applicationsTranslational and Clinical Pharmacology · 2020
  40. Possibility of pharmacokinetic drug interaction between a DPP-4 inhibitor and a SGLT2 inhibitorTranslational and Clinical Pharmacology · 2020
  41. Predicting human pharmacokinetics from preclinical data: volume of distributionTranslational and Clinical Pharmacology · 2020
  42. Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labelsTranslational and Clinical Pharmacology · 2020
  43. Qualification and application of liquid chromatography-quadrupole time-of-flight mass spectrometric method for the determination of carisbamate in rat plasma and prediction of its human pharmacokinetics using physiologically based pharmacokinetic modelingTranslational and Clinical Pharmacology · 2020
  44. Complex influences of gut microbiome metabolism on various drug responsesTranslational and Clinical Pharmacology · 2020
  45. Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjectsTranslational and Clinical Pharmacology · 2020
  46. Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapyTranslational and Clinical Pharmacology · 2020
  47. Development and validation of a method for the simultaneous quantification of endogenous steroids metabolized by CYP3ATranslational and Clinical Pharmacology · 2020
  48. Bioequivalence data analysisTranslational and Clinical Pharmacology · 2020
  49. Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjectsTranslational and Clinical Pharmacology · 2020
  50. A review of computational drug repurposingTranslational and Clinical Pharmacology · 2019